# U03 PR #89 Merge Authorization Targeted Re-Review v0.1

> 对象：PR #89 在 `BF-MAR-01 = STALE_AUTHORITATIVE_STATUS_DOCUMENTS` 修复后的定向再审。  
> 前序审查：`U03_PR89_Merge_Authorization_Review_v0.1.md` = `REVISE_REQUIRED`。  
> 修复范围：仅同步 `U03_Clinical_Dependency_Readiness.md` 与 `U03_Clinical_Content_Governance_Status.md`。  
> 审核角色：`U03_TECHNICAL_GOVERNANCE_REVIEW`  
> 审核日期：`2026-09-16`  
> 状态：`TARGETED_MERGE_AUTH_REVIEW_COMPLETE / PASS / NOT_MERGE_AUTHORIZATION`。

## 1. Scope

本次只确认：

```text
M5 blocker 是否关闭
status sync 是否仅修正 Gate C 后状态
是否夹带 CD-07 / U04 / runtime / production / merge 授权
是否改变 evaluator / cases / workflow / clinical semantics
```

不重开：

```text
Gate A / Gate B / Gate C
Independent Implementation Review
Targeted Evidence-Capture Review
Governed Evaluation Re-Execution
Evidence Freeze
Gate C Re-Decision
Post-Gate-C PG-01..PG-04
```

## 2. Change Isolation

GitHub compare：

```text
d2b01a3b6ae1167a703a1950df22af98cb65f1ec
→ 948f18d666709df3b380261e5626e1a90d27f527

commits = 2
files changed = 2

U03_Clinical_Dependency_Readiness.md
U03_Clinical_Content_Governance_Status.md
```

未修改：

```text
tools/u03_gatec_eval/*
.github/workflows/u03-gatec-eval.yml
clinical rule / threshold / fixture / expected outcome
runtime code
StateCommitter
U04 / U14 wiring
production path
```

因此该修复是 status-only sync。

## 3. BF-MAR-01 Closure

两份权威状态文件现在统一声明：

```text
Gate A = PASS
Gate B = PASS / GOVERNED_CONTENT_READY
Gate C = PASS
Governed Evaluation Re-Execution = COMPLETED / PASS
Governed Evaluation Evidence = FROZEN / VERIFIED
BF-CD06-EXEC-01 = CLOSED
BF-GATEC-EVIDENCE-01 = CLOSED
```

并继续明确：

```text
CD-07 Implementation Readiness = NOT_READY
CD-07 Implementation Authorization = NOT_GRANTED
Runtime Implementation Authorization = NOT_GRANTED

U04 Implementation Readiness = NOT_READY
U04 blocker = BLOCKED_BY_U03_RUNTIME_CLINICAL_DEPENDENCY
U04 Implementation Authorization = NOT_GRANTED

current governed releases = candidate / NOT_PUBLISHED / NOT_ACTIVE_FOR_RUNTIME
Clinical Runtime Production = NOT_ENABLED
Production Authorization = BLOCKED
Merge Authorization = NOT_GRANTED
```

因此旧的 `Gate C = NOT_PASSED` / `Evaluation Execution = NOT_STARTED/BLOCKED` 权威冲突已消除，且没有把 Gate C PASS 放大为 runtime / U04 / production / merge 授权。

```text
BF-MAR-01 = CLOSED
```

## 4. M1-M6 Re-Decision

| ID | Question | Verdict |
|---|---|---|
| M1 | 合入物是否仍仅覆盖 AUTH-U03-GATEC-EVAL-IMPL-001 / evaluation-only scope | PASS |
| M2 | 是否无 C02/D09 runtime、U04、production commit/network 越权 | PASS |
| M3 | Gate C PASS 是否未把 candidate 写成 ACTIVE_FOR_RUNTIME/PRODUCTION | PASS |
| M4 | eval-only harness 与治理记录是否可作为已完成 Gate C 证据工具进入基线 | PASS |
| M5 | 权威 status/readiness 文档是否已同步到 Gate C PASS 且保持后续 blocker | PASS / BF-MAR-01 CLOSED |
| M6 | 是否仍要求 Repository Owner 显式 Merge Authorization | PASS / STILL_REQUIRED |

new blocking finding = 0

## 5. Decision

```text
Historical Merge Authorization Review = REVISE_REQUIRED
BF-MAR-01 = CLOSED
Targeted Merge Authorization Re-Review = PASS
new blocking findings = 0

PR #89 = ELIGIBLE_FOR_EXPLICIT_MERGE_AUTHORIZATION
Merge Authorization = NOT_GRANTED
PR #89 = KEEP_DRAFT UNTIL EXPLICIT AUTHORIZATION
```

本 PASS 只表示：PR #89 现在可以由 Repository Owner 做显式 Merge Authorization 决策。

它不表示：

```text
CD-07 Implementation Authorization
C02/D09 runtime authorization
U04/U14 implementation authorization
release activation
Clinical Runtime enabled
Production Authorization
```

若后续 Repository Owner 显式授权 merge，仍必须：

```text
re-check exact PR HEAD
standard merge commit only
no squash
no rebase
no auto-merge
post-merge verification after merge
```

在显式 Merge Authorization 之前不得执行 merge。
